These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Medication-related impulse control and repetitive behaviors in Parkinson disease. Voon V; Fox SH Arch Neurol; 2007 Aug; 64(8):1089-96. PubMed ID: 17698698 [TBL] [Abstract][Full Text] [Related]
43. [L-dopa effectiveness decreases over time. What helps Parkinson patients stay mobile?]. Wedekind S MMW Fortschr Med; 2005 Jun; 147(22):10. PubMed ID: 15977622 [No Abstract] [Full Text] [Related]
44. Clozapine prevents recurrence of psychosis in Parkinson's disease. Factor SA; Brown D Mov Disord; 1992; 7(2):125-31. PubMed ID: 1350059 [TBL] [Abstract][Full Text] [Related]
45. Drug therapies for Parkinson's disease: A database analysis of patient compliance and persistence. Tarrants ML; Denarié MF; Castelli-Haley J; Millard J; Zhang D Am J Geriatr Pharmacother; 2010 Aug; 8(4):374-83. PubMed ID: 20869623 [TBL] [Abstract][Full Text] [Related]
46. Medical hazards of the internet: gambling in Parkinson's disease. Larner AJ Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457 [No Abstract] [Full Text] [Related]
47. Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy. Melamed E; Zoldan J; Friedberg G; Ziv I; Weizmann A Adv Neurol; 1996; 69():545-50. PubMed ID: 8615179 [No Abstract] [Full Text] [Related]
48. Pharmacotherapy for Parkinson's disease: current options, promising future therapies. Moser SS; Besler-Panos W JAAPA; 2006 Aug; 19(8):38-44. PubMed ID: 16918085 [No Abstract] [Full Text] [Related]
49. Pathological gambling in Parkinson's disease: disease related or drug related? Calandrella D; Antonini A Expert Rev Neurother; 2011 Jun; 11(6):809-14. PubMed ID: 21651329 [TBL] [Abstract][Full Text] [Related]
50. [Between Scylla and Charybdis: drug-induced psychosis in patients with Parkinson disease]. Kuiper MA; Zwaan WA; Wolters EC Ned Tijdschr Geneeskd; 1994 Jul; 138(27):1353-7. PubMed ID: 8035892 [No Abstract] [Full Text] [Related]
52. L-dopa treatment duration versus Parkinson's disease progression: the dorsal-ventral divide. Belujon P; Grace AA Mov Disord; 2013 Feb; 28(2):120-1. PubMed ID: 23401218 [No Abstract] [Full Text] [Related]
53. Text messaging as a new compulsive behavior in a patient with Parkinson's disease. Ertem DH; Maner F; Koksal A Psychiatry Clin Neurosci; 2013 Feb; 67(2):126-7. PubMed ID: 23438166 [No Abstract] [Full Text] [Related]
54. The thrill of reckless driving in patients with Parkinson's disease: an additional behavioural phenomenon in dopamine dysregulation syndrome? Avanzi M; Baratti M; Cabrini S; Uber E; Brighetti G; Bonfà F Parkinsonism Relat Disord; 2008; 14(3):257-8. PubMed ID: 17561433 [TBL] [Abstract][Full Text] [Related]